MDM4 Isoform Expression in Melanoma Supports an Oncogenic Role for MDM4-A
The p53 tumor suppressor integrates upstream signals such as DNA damage and active oncogenes to initiate cell cycle arrest or apoptosis. This response is critical to halting inappropriate growth signals. As such, p53 activity is lost in cancer. In melanoma, however, the p53 gene is intact in a repor...
Saved in:
Main Authors: | Abdullah Alatawi, SoonJye Kho, Michael P. Markey |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Skin Cancer |
Online Access: | http://dx.doi.org/10.1155/2021/3087579 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ezetimibe Anticancer Activity via the p53/Mdm2 Pathway
by: Charmy Twala, et al.
Published: (2025-01-01) -
MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis
by: Vishesh Khanna, et al.
Published: (2025-02-01) -
Autoantibody to MDM2: A Potential Serological Marker of Systemic Lupus Erythematosus
by: Yuan Liu, et al.
Published: (2015-01-01) -
Targeting MDM2 affects spastin protein levels and functions: implications for HSP treatment
by: Francesca Sardina, et al.
Published: (2025-02-01) -
Study some two loop contribution to muon anomalous MDM in the N-B-LSSM
by: Xing-Yu Han, et al.
Published: (2025-02-01)